Analyses of the Kaplan–Meier plotter datasets demonstrated that lower RSPH14 mRNA expression levels had a longer overall survival time than those with high RSPH14 mRNA expression levels in patients with NSCLC (Fig. 1C) and male patients with NSCLC (Fig. 1D). The gene discussed is RSPH14; the disease is non-small cell lung carcinoma.